Cipher Pharmaceuticals Financial Overview
Cipher Pharmaceuticals's market cap is currently $375.57M. The company's EPS TTM is C$0.29611079609999996; its P/E ratio is 22.40; Cipher Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is C$0.21. See an overview of income statement, balance sheet, and cash flow financials.
